ANTARES PHARMA Trademark

Trademark Overview

On Thursday, July 25, 2002, a trademark application was filed for ANTARES PHARMA with the United States Patent and Trademark Office. The USPTO has given the ANTARES PHARMA trademark a serial number of 78147508. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, December 7, 2016. This trademark is owned by Antares Pharma, Inc.. The ANTARES PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research in drug delivery systems, transdermal drugs and transdermal drug delivery systems; pharmaceutical products design and development for others
antares pharma

General Information

Serial Number78147508
Word MarkANTARES PHARMA
Filing DateThursday, July 25, 2002
Status800 - REGISTERED AND RENEWED
Status DateWednesday, December 7, 2016
Registration Number3150417
Registration DateTuesday, October 3, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 11, 2006

Trademark Statements

Disclaimer with Predetermined Text"PHARMA"
Goods and ServicesMedical research in drug delivery systems, transdermal drugs and transdermal drug delivery systems; pharmaceutical products design and development for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2002
Primary Code042
First Use Anywhere DateWednesday, January 31, 2001
First Use In Commerce DateThursday, March 15, 2001

Trademark Owner History

Party NameAntares Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEwing, NJ 08618
Party NameAntares Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEwing, NJ 08618
Party NameAntares Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressExton, PA 19341

Trademark Events

Event DateEvent Description
Wednesday, December 7, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, December 7, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, December 7, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, December 7, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 28, 2016TEAS SECTION 8 & 9 RECEIVED
Saturday, October 3, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, May 30, 2012NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Wednesday, May 30, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, May 30, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 10, 2012TEAS SECTION 8 RECEIVED
Wednesday, January 16, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 16, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 3, 2006EXPARTE APPEAL TERMINATED
Tuesday, October 3, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, August 8, 2006TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 11, 2006PUBLISHED FOR OPPOSITION
Wednesday, June 21, 2006NOTICE OF PUBLICATION
Tuesday, May 23, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 5, 2006ASSIGNED TO LIE
Saturday, April 29, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2006EXAMINER'S AMENDMENT ENTERED
Wednesday, April 26, 2006EXAMINERS AMENDMENT E-MAILED
Wednesday, April 26, 2006EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 25, 2006ATTORNEY REVIEW COMPLETED
Wednesday, April 5, 2006PETITION GRANTED - TTAB APPEAL FILED
Thursday, March 16, 2006PETITION TO REVIVE-RECEIVED
Thursday, March 16, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 16, 2006TEAS PETITION TO REVIVE RECEIVED
Thursday, March 16, 2006EXPARTE APPEAL TERMINATED
Thursday, March 16, 2006EX PARTE APPEAL-INSTITUTED
Thursday, March 16, 2006EXPARTE APPEAL RECEIVED AT TTAB
Monday, March 6, 2006ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, March 4, 2006ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, August 6, 2005FINAL REFUSAL E-MAILED
Saturday, August 6, 2005FINAL REFUSAL WRITTEN
Friday, July 15, 2005LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, November 29, 2004REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, September 15, 2003LETTER OF SUSPENSION E-MAILED
Monday, July 7, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 21, 2003CASE FILE IN TICRS
Monday, July 7, 2003TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 9, 2003NON-FINAL ACTION E-MAILED
Tuesday, December 10, 2002ASSIGNED TO EXAMINER

Related Keywords

pharma antares systems delivery transdermal drug design development others products pharmaceutical research